伴t(11;19)(q23;p13.1)恶性血液病的临床和实验室特征

伴t(11;19)(q23;p13.1)恶性血液病的临床和实验室特征

作者：谭丽， 刘芯， 曾金财， 杨少江， 吴晓鸿， Tan Li， Liu Xin， Zeng Jincai， Yang Shaojiang，Wu Xiaohong

作者单位：510230,广州医科大学附属第一医院海印院区肿瘤血液中心

刊名：

白血病·淋巴瘤

英文刊名：Journal of Leukemia & Lymphoma

年，卷(期)：2015,24(1)

1.张之南;沈悌血液病诊断及疗效标准 1998

2.Moorman AV;Hagemeijer A;Charrin C;Rieder H;Secker-Walker LM The translocations, t(11;19)(q23;p1

3.1) and

t(11;19)(q23;p13.3): a cytogenetic and clinical profile of 53 patients. European 11q23 Workshop participants.[外文期刊] 1998(5)

3.Vardiman JW;Harris NL;Brunning RD The World Health Organization (WHO) classification of the myeloid neoplasms.[外文期刊] 2002(7)

4.Mitani K;Kanda Y;Ogawa S Cloning of several species of MLL/MEN chimeric cDNAs in myeloid leukemia with t

(11;19)(q23;p13.1) translocation 1995(8)

5.Thirman M J;Levitan DA;Kobayashi H Cloning of ELL,a gene that fuses to MLL in a t (11;19) (q23;p13.1) in acute myeloid leukemia 1994(25)

6.Zhang W;Ji W;Liu X ELL inhibits E2F1 transcriptional activity by enhancing E2F1 deacetylation via recruitment of histone deacetylase 1 2014(4)

7.Shah CA;Bei L;WangH;Platanias LC The leukemiaassociated Mll-Ell oncoprotein induces fibroblast growth factor 2 (Fgf2)-dependent cytokine hypersensitivity in myeloid progenitor cells 2013(45)

8.Tuborgh A;Meyer C;Marschalek R Complex three-way translocation involving MLL,ELL,RREB1,and CMAHP genes in an infant with acute myeloid leukemia and t (6;19;11) (p22.2;p13.1;q23.3) 2013(1)

9.Tamai H;Inokuchi K11 q23/MLL acute leukemia:update of clinical aspects 2010(2)

10.Poppe B;Vandesompele J;Schoch C Expression analyses identify MLL as a prominent target of 1 1q23 amplification and support an etiologic role for MLL gain of function in myeloid malignancies 2004(1)

引用本文格式：谭丽.刘芯.曾金财.杨少江.吴晓鸿.Tan Li.Liu Xin.Zeng Jincai.Yang Shaojiang.Wu Xiaohong伴

t(11;19)(q23;p13.1)恶性血液病的临床和实验室特征[期刊论文]-白血病·淋巴瘤 2015(1)